In this final (honorary) sit-down from the JP Morgan Chase Healthcare Conference in San Francisco last month, pharmaphorum editor-in-chief Jonah Comstock chats virtually with Joe Spinelli, SVP prod
GSK’s Arexvy has become the first vaccine for respiratory syncytial virus (RSV) to be approved in the EU, getting the nod from the European Commission for use in older adu
Health systems globally have reached a critical inflexion point, where ageing populations and tightening budgets mean we can no longer continue to purely treat late-stage symptomatic diseas